ArticleMedicine2026
Sequential manifestation of Kaposi's sarcoma and diffuse large B-cell lymphoma in the context of HIV infection: Case report of a rare presentation.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
rationaleKaposi sarcoma (KS) and diffuse large B-cell lymphoma (DLBCL) are AIDS-defining malignancies frequently linked to HIV-related immune dysregulation. Their sequential occurrence in a single patient is an uncommon and clinically significant phenomenon. PATIENT CONCERNS: Herein, we report a case of sequential occurrence of KS and DLBCL that underscores the complex interplay between HIV infection, immune suppression, and oncogenesis. DIAGNOSES: At the time of HIV diagnosis (which prompted the immediate initiation of antiretroviral therapy), the patient, a 46-year-old man, exhibited symptoms (generalized rash, bowel movements) raising clinical suspicion for KS. This was confirmed through clinical examinations, including skin biopsy and colonoscopy.
interventionsThe patient received treatment with paclitaxel and doxorubicin for KS. One year later, he developed DLBCL, presenting with back and flank pain, and was subsequently treated with the R-CHOP regimen. OUTCOMES: The patient demonstrated a favorable therapeutic response to both treatment regimens. LESSONS: This case underscores the clinical challenges and importance of vigilance in managing sequential AIDS-defining malignancies. It also highlights the need for systematic guidelines for screening oncogenic viruses in HIV-infected individuals, particularly those with prior KS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.